Diagenode

miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis


Zhang S. et al.

Read More

Tags
Antibody

Share this article

Published
March, 2017

Source

Products used in this publication

  • Mouse IgG
    C15200200
    5-hydroxymethylcytosine (5-hmC) monoclonal anti...

活动

  • Pacbio PRISM
    Danang, Vietnam
    Apr 14-Apr 16, 2025
  • American Association of Cancer Research (AACR)
    Chicago (IL), USA
    Apr 25-Apr 30, 2025
 查看所有活动

 


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy